Drugs / Allogeneic Adult Human Mesenchymal Stem Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02013700 | Nov 2013 → Dec 2015 | idiopathic pulmonary fibrosis | Joshua M Hare | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Adult Human Mesenchymal Stem Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02013700 ↗ |
| Known as | hMSCs | “Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)” NCT02013700 ↗ |
| Modality | Cell therapy | “allogenic mesenchymal stem cells” NCT02013700 ↗ |
| Route | Intravenous | “delivered via peripheral intravenous infusion” NCT02013700 ↗ |